[Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)].
D000328:Adult; D000904:Antibiotics, Antitubercular / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D010455:Peptides / Q000494:pharmacology / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014756:Viomycin / Q000494:pharmacology / Q000627:therapeutic use*
D000904:Antibiotics, Antitubercular; D010455:Peptides; D014756:Viomycin